

The main goal is to assess project management maturity in a sample of companies that involve biotechnology processes, identifying their main weaknesses and strengths in project management. This paper contributes to the development of project management in companies that integrate biotechnology in their processes, given the increasing importance of this sector under the current context. After a detailed morphological analysis of the models, it is concluded that OPM3® is the most promising maturity model that can really provide a competitive advantage to the organizations due to its unique approach of assessment and improvement strategies. This study presents a critical evaluation of some of the leading PMMMs against OPM3® in a multitude of ways to look at which PMMM is the most comprehensive model - which could assess most aspects of organizations and also help the organizations in gaining competitive advantage over competitors. Organizations have developed several project management maturity models (PMMMs) to assess project management maturity of the organizations. Therefore, organizations are striving to standardize and assess the rigor of their project management processes and capabilities i.e.

There exists a strong correlation between efficient project management and competitive advantage for organizations.
